Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Tobacco Use Disorder 3Small Cell Lung Carcinoma 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Smoking Cessation 2Pancreatic Neoplasms 2Overweight 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Obesity 2Nasopharyngeal Neoplasms 2Mouth Neoplasms 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Kidney Neoplasms 2Hypopharyngeal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Advanced Solid Tumor 2Vulvar Neoplasms 1Vaginal Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Escitalopram 2Transcranial Magnetic Stimulation 1Sugars 1Saline Solution 1Mirtazapine 1Magnetic Resonance Spectroscopy 1Ketamine 1Interpersonal Psychotherapy 1Infliximab 1Diagnostic Imaging 1Cognitive Behavioral Therapy 1Citalopram 1Bupropion 1Antidepressive Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Depressive Disorder, Major × Bupropion × Clear all
NCT00234195 2007-04-17

Wellbutrin XL, Major Depressive Disorder and Breast Cancer

Thomas Jefferson University

Phase 4 Completed
25 enrolled
Breast

Breast Neoplasms, Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon âš¡